Two drugs from a class new to HIV medicine called BH3 mimetics were unveiled at

A CRISPR-based gene-editing therapy known as EBT-101 was not associated with serious

Gene editing with CRISPR/Cas9 can lead to unwanted ‘cuts’ and changes in the gene sequences

A CRISPR-based gene-editing therapy called EBT-101 was safe and well tolerated but